Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

July 20, 2017

Dohmen leads keynote panel at Patient Support Services and HUB Design Summit, July 24-25

Patients are empowered like never before. That's why Dohmen is excited to showcase its patient journey expertise at the 4th Annual World Congress Patient Support Services and HUB Design Summit, July 24-25, in Philadelphia.

This summit brings together orphan drug manufacturers, BPOs, doctors, researchers and more to build better awareness of patients’ needs and sparks important conversations around whether rare disease therapies provide the support and services needed to drive adherence.
 
Marie E. Lamont, President of Patient Services for Dohmen Life Science Services, will participate in the summit’s keynote panel – Voice of the Patient: Understand the Patient Journey to Enhance Channel Strategies and Ensure an Optimal Patient Experience on Monday July, 24 at 11:45 a.m. The panel includes patients and advocates sharing their firsthand experiences with specialty therapies and the challenges they face. 
 
DLSS is proud to be part of this year’s World Congress Patient Support Services and HUB Design Summit and sponsor its mission of developing strategies to uncover patient value, enhance HUB performance and expand value-added services in patient support services. Visit the Annual World Congress Patient Support Services and HUB Design Summit web site for more information.